Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-02-24FDA Approved: RISPERIDONE — Original Application (Amici Pharma, Inc.)
FDA approves the original application for a risperidone generic from Amici Pharma, Inc.
-
FDA approval · 2009-02-19FDA Approved: LAMOTRIGINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved an original application for a generic lamotrigine product manufactured by Glenmark Pharmaceuticals Inc., expanding generic …
-
FDA approval · 2009-02-03FDA Approved: LITHIUM CARBONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for lithium carbonate, making the generic mood stabilizer available for use in bipolar disorder.
-
FDA approval · 2009-01-30FDA Approved: RISPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for risperidone, adding a generic version of the antipsychotic.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's Original Application for lamotrigine, enabling a generic lamotrigine product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE KIT — Original Application (OWP Pharmaceuticals, Inc.)
FDA approves Lamotrigine Kit under an original ANDA application by OWP Pharmaceuticals, Inc. for generic lamotrigine products.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals Inc.'s original ANDA for lamotrigine, establishing a generic lamotrigine product.
-
FDA approval · 2009-01-27FDA Approved: DIVALPROEX SODIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved an original application for a generic divalproex sodium product from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original ANDA for Lamotrigine from Aurobindo Pharma Limited, providing a generic lamotrigine product. The product is ind…
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' generic lamotrigine under Original Application (ANDA). The approval covers the generic product for la…
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for lamotrigine from Zydus Pharmaceuticals USA Inc., establishing a generic version of the anti-epileptic and…
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original ANDA for lamotrigine, enabling a generic lamotrigine product to reach the market.
-
FDA approval · 2009-01-23FDA Approved: DIVALPROEX SODIUM — Original Application (NorthStar Rx LLC)
The FDA approved NorthStar Rx LLC's original application for divalproex sodium (generic).
-
FDA approval · 2009-01-22FDA Approved: LAMOTRIGINE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for lamotrigine, a generic version manufactured by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2009-01-22FDA Approved: LAMOTRIGINE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved the Original Application for Lamotrigine as a generic product from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-01-12FDA Approved: LITHIUM CARBONATE LITHIUM CARBONATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic lithium carbonate under an original ANDA. The product is used as a mood stabilizer for bipolar…
-
FDA approval · 2008-11-25FDA Approved: DIVALPROEX SODIUM — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's original application for divalproex sodium, making a generic version available for epilepsy, bipolar disorder, and…
-
FDA approval · 2008-11-25FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for HALOPERIDOL (generic) from PAI Holdings, LLC dba PAI Pharma under ANDA073037.
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC).
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, approving changes to the approved d…
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action updates the ap…
-
FDA approval · 2008-10-30FDA Approved: RISPERIDONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for risperidone, providing a generic version of the antipsychotic.
-
FDA approval · 2008-10-16FDA Approved: RISPERIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved an original abbreviated new drug application for risperidone by Zydus Lifesciences Limited, enabling the sale of a generic risp…
-
FDA approval · 2008-09-08FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application from Actavis Pharma, Inc. for LOXAPINE (loxapine), establishing a generic loxapine product.
-
FDA approval · 2008-08-14FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine), adding an intramuscular formulation to the product. This…